✦ LIBER ✦

Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study

✍ Scribed by Corn, Paul G.; Song, Danny Y.; Heath, Elisabeth; Maier, Jordan; Meyn, Raymond; Kuban, Deborah; DePetrillo, Thomas A.; Mathew, Paul

Book ID: 123146751
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 191 KB
Volume: 86
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.12.029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multi-institutional Outcomes Following E

Multi-institutional Outcomes Following External Beam Radiation Therapy and Androgen Deprivation Therapy in Patients With Extreme-Risk Prostate Cancer

✍ Gomez-Iturriaga, A.; Cabeza, M.; Pastor, J.; Jove, J.; Casaña, M.; Mengual, J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Intense Androgen-Deprivation Therapy Wit

Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

✍ Taplin, M.-E.; Montgomery, B.; Logothetis, C. J.; Bubley, G. J.; Richie, J. P.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 316 KB

Best oral presentation: Multi-institutio

Best oral presentation: Multi-institutional outcomes following external beam radiation therapy and androgen deprivation therapy in patients with extreme-risk prostate cancer

✍ Gomez-iturriaga, A.; Cabeza, M.; Pastor, J.; Jove, J.; Casaña, M.; Mengual, J.; 📂 Article 📅 2013 🏛 Wielkopolskie Centrum Onkologii 🌐 Polish ⚖ 55 KB

Concurrent and adjuvant docetaxel with t

Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial

✍ Michel Bolla; Jean Michel Hannoun-Levi; Jean-Marc Ferrero; Philippe Maingon; Joë 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 276 KB

34 Phase 2 study of neoadjuvant docetaxe

34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP)

✍ M. McKenzie; K. Chi; A. Neville; S. Ellard; B. Baerg; D. Ruether; E. Winquist; R 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 258 KB

Multicenter phase 2 study of neoadjuvant

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer : Results of Cancer and Leukemia Group B 99811

✍ William Kevin Kelly; Susan Halabi; Aymen Elfiky; San-San Ou; Jeff Bogart; Michae 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 1 views